Lifitegrast for the Treatment of Dry Eye Disease (OPUS)


January 1, 2017

Clinical Trial

Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3).

Holland EJ, Luchs J, Karpecki PM, Nichols KK, Jackson MA, Sall K, Tauber J, Roy M, Raychaudhuri A, Shojaei A.

Ophthalmology. 2017 Jan;124(1):53-60.
Full text | Metrics.

December 1, 2015

Clinical Trial

Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.

Tauber J, Karpecki P, Latkany R, Luchs J, Martel J, Sall K, Raychaudhuri A, Smith V, Semba CP.

Ophthalmology. 2015 Dec;122(12):2423-31.
Full text | Metrics.

February 1, 2014

Clinical Trial

Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.

Sheppard JD, Torkildsen GL, Lonsdale JD, D’Ambrosio FA Jr, McLaurin EB, Eiferman RA, Kennedy KS, Semba CP.

Ophthalmology. 2014 Feb;121(2):475-83.
Full text | Metrics.

Share This Article :

Updated on March 7th, 2022

Source Archive